CatalystWireBeta

Genflow Biosciences

GENF · Main Market · Health Care · mcap £11m · 1.8p

Beta Briefing, track record and signals & risks are not ready for Genflow Biosciences yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Jonathan Mark Swann 30 Jan · 1 notice
11.3% → 12.1%
share price at the notices 1.9p · now 1.8p 30 Jan 2026
On October 23 24 Oct · 1 notice
8.4% → 11.3%
share price at the notices 2.2p · now 1.8p 24 Oct 2025

Directors and managers

Last 12 months: bought £18k in 1 trade by 1 person · no market sales

Own-money trades (bought or sold in the market) say most about what insiders think. Awards, vesting, shares sold to cover tax, fees and dividends taken in shares are part of pay.

DatePersonTransactionSharesPriceValue
05 Mar 26 1. Eric Leire 2. Gad BerdugoDirector/PDMR Buy in placing 965,789 1.9p £18k
09 Oct 25 Eric LeirePDMR Buy in placing 40,000,000 1.1p £440k

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note